<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00485706</url>
  </required_header>
  <id_info>
    <org_study_id>ML4181</org_study_id>
    <secondary_id>S50455</secondary_id>
    <nct_id>NCT00485706</nct_id>
  </id_info>
  <brief_title>Arterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis Patients</brief_title>
  <official_title>Arterial Stiffness and Decreased Bone Buffering Capacity in Hemodialysis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Renal patients have an increased risk for cardiovascular complications. There is also
      increased vascular calcification and bone metabolism is similarly abnormal in patients with
      chronic kidney disease.

      In dialysis patients frequent episodes of hypercalcaemia occur. In a healthy bone structure
      those episodes of hypercalcemia are buffered by the bone. The absence of bone buffering
      capacity in dialysis patients can be a mechanism for vascular calcifications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study hypothesis.

      Patient with a higher ∆ Calcium (Calcium post - Calcium pre) have a diminished bone buffering
      capacity indicative for adynamic bone disease compared with patients with smaller ∆ Calcium.

      This may result in higher extraosseous calcification and higher pulse wave velocity

      ∆ PTH/∆ Calcium may reflect the sensitivity and density of the calcium receptors; this may
      reflect parathyroid &quot;health&quot;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>correlation between calcium increase and pulse wave velocity</measure>
    <description>correlation between calcium increase and pulse wave velocity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>correlation between calcium change and pth change</measure>
    <description>correlation between calcium change and pth change</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>correlation between calcium increase and vascular calcifications</measure>
    <description>correlation between calcium increase and vascular calcifications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>correlation between calcium change and bone markers</measure>
    <description>correlation between calcium change and bone markers</description>
  </secondary_outcome>
  <condition>Kidney Disease</condition>
  <condition>Hypercalcemia</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>high calcium dialysate</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  maintenance hemodialysis patients

        Exclusion Criteria:

          -  dialysis &lt;3 months

          -  aortobifemoral graft

          -  calcium level predialysis &gt;10.5 mg/dl
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>kathleen Claes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Gasthuisberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UZ Gasthuisberg</name>
      <address>
        <city>LEuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>June 12, 2007</study_first_submitted>
  <study_first_submitted_qc>June 12, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2007</study_first_posted>
  <last_update_submitted>October 15, 2018</last_update_submitted>
  <last_update_submitted_qc>October 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dialysis</keyword>
  <keyword>vascular calcification</keyword>
  <keyword>bone mineralism</keyword>
  <keyword>arterial stiffness</keyword>
  <keyword>bone metabolism</keyword>
  <keyword>chronic kidney disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Hypercalcemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dialysis Solutions</mesh_term>
    <mesh_term>Calcium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

